Live Breaking News & Updates on Madrigal Pharmaceuticals Company Profile

Stay updated with breaking news from Madrigal pharmaceuticals company profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Paulson & CO. Inc. Grows Stock Holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)

Paulson & CO. Inc. increased its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by 121.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,105,741 shares of the biopharmaceutical company’s stock after purchasing an additional 605,741 shares during the quarter. Madrigal […] ....

United States , Jamesm Daly , Wolfe Research , Quarter For Madrigal Pharmaceuticals , Madrigal Pharmaceuticals Company Profile , Exchange Commission , News Ratings For Madrigal Pharmaceuticals Daily , Madrigal Pharmaceuticals Stock , Global Retirement Partners , Harbor Financial Group , Montaga Associates Inc , Xponance Inc , Madrigal Pharmaceuticals Inc , Madrigal Pharmaceuticals , Free Report , Retirement Partners , New Harbor Financial Group , Director James , Director Fred , Get Free Report , Visit Holdingschannel , Madrigal Pharmaceuticals Daily ,

Madrigal Pharmaceuticals (NASDAQ:MDGL) Upgraded by StockNews.com to "Sell"

Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) was upgraded by research analysts at StockNews.com to a “sell” rating in a research report issued to clients and investors on Wednesday. Other equities research analysts also recently issued research reports about the company. Piper Sandler restated an “overweight” rating and set a $336.00 price target on shares […] ....

New York , United States , Piper Sandler , Roberte Waltermire , Madrigal Pharmaceuticals Inc , York State Common Retirement Fund , Madrigal Pharmaceuticals , Analyst Recommendations For Madrigal Pharmaceuticals , Charles Schwab Investment Management Inc , Canaccord Genuity Group , News Ratings For Madrigal Pharmaceuticals Daily , Madrigal Pharmaceuticals Price Performance , Securities Exchange Commission , Jp Morgan Private Wealth Advisors , Jump Financial , Hedge Funds Weigh In On Madrigal Pharmaceuticals , Madrigal Pharmaceuticals Company Profile , Get Free Report , Exchange Commission , Director Fred , Private Wealth Advisors , Charles Schwab Investment Management , Schwab Investment Management , Madrigal Pharmaceuticals Daily ,

Madrigal Pharmaceuticals (NASDAQ:MDGL) Upgraded by StockNews.com to "Sell"

Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) was upgraded by research analysts at StockNews.com to a “sell” rating in a research report issued to clients and investors on Wednesday. Other equities research analysts also recently issued research reports about the company. Piper Sandler restated an “overweight” rating and set a $336.00 price target on shares […] ....

New York , United States , Roberte Waltermire , Piper Sandler , Canaccord Genuity Group , Charles Schwab Investment Management Inc , Madrigal Pharmaceuticals Company Profile , Hedge Funds Weigh In On Madrigal Pharmaceuticals , Jump Financial , Jp Morgan Private Wealth Advisors , Securities Exchange Commission , Madrigal Pharmaceuticals Price Performance , News Ratings For Madrigal Pharmaceuticals Daily , Madrigal Pharmaceuticals Inc , Analyst Recommendations For Madrigal Pharmaceuticals , York State Common Retirement Fund , Madrigal Pharmaceuticals , Get Free Report , Exchange Commission , Director Fred , Private Wealth Advisors , Charles Schwab Investment Management , Schwab Investment Management , Madrigal Pharmaceuticals Daily ,

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL) Receives Average Recommendation of "Moderate Buy" from Analysts

Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) have received an average recommendation of “Moderate Buy” from the eleven analysts that are currently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell rating, one has given a hold rating and nine have issued a buy rating on the […] ....

United States , Piper Sandler , Rebecca Taub , Canaccord Genuity Group , Analyst Recommendations For Madrigal Pharmaceuticals , Global Retirement Partners , Madrigal Pharmaceuticals Inc , Madrigal Pharmaceuticals Stock Performance , Entrypoint Capital , Madrigal Pharmaceuticals , Montaga Associates Inc , Madrigal Pharmaceuticals Company Profile , News Ratings For Madrigal Pharmaceuticals Daily , Get Free Report , Genuity Group , Director Fred , Retirement Partners , Point Capital , Get Free , Madrigal Pharmaceuticals Daily ,

Madrigal Pharmaceuticals (NASDAQ:MDGL) Issues Quarterly Earnings Results, Misses Estimates By $1.32 EPS

Madrigal Pharmaceuticals (NASDAQ:MDGL) Issues Quarterly Earnings Results, Misses Estimates By $1.32 EPS
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

United States , Richards Levy , Piper Sandler , Paula Friedman , Madrigal Pharmaceuticals Stock Down , Canaccord Genuity Group , Madrigal Pharmaceuticals , Madrigal Pharmaceuticals Company Profile , News Ratings For Madrigal Pharmaceuticals Daily , Madrigal Pharmaceuticals Inc , Securities Exchange Commission , Insider Activity At Madrigal Pharmaceuticals , Earnings History For Madrigal Pharmaceuticals , Get Free Report , Pharmaceuticals Stock Down , Director Paul , Director Richard , Exchange Commission , Madrigal Pharmaceuticals Daily ,